Klogene Therapeutics, Inc.
Creating therapeutics to prevent and treat age-related diseases by boosting natural Klotho protein levels in the body
Creating therapeutics to prevent and treat age-related diseases by boosting natural Klotho protein levels in the body
Klogene Therapeutics, Inc. is a biotechnology startup founded in 2015. The company's slogan, “Creating therapeutics to prevent and treat age-related diseases by boosting natural Klotho protein levels in the body,” encompasses its core mission. Klogene is focused on developing therapeutics for the prevention and treatment of age-related diseases by manipulating the levels of the naturally occurring Klotho protein in the human body. The company received a significant $310.00K Pre-Seed Round investment on 01 July 2018. While the specific investors involved in this funding round were not disclosed, this injection of capital provides Klogene with resources to further its research and development efforts in the Biotechnology and Health Care industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $310.00K | - | 01 Jul 2018 | |
| Seed Round | $1.49M | - | 01 Aug 2016 |
No recent news or press coverage available for Klogene Therapeutics, Inc..
We care about your data, and we'd love to use cookies make your experience better.
